ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Methicillin-Susceptible Staphylococcus Aureus Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-29N8368
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Methicillin Susceptible Staphylococcus Aureus Market Insights Forecast to 2028
BUY CHAPTERS

Global Methicillin-Susceptible Staphylococcus Aureus Market Research Report 2025

Code: QYRE-Auto-29N8368
Report
July 2025
Pages:71
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Dainippon Sumitomo Pharma Co., Ltd
Immtech Pharmaceuticals, Inc.
Lytix Biopharma AS
PharmaIN Corporation
Cubist Pharmaceuticals
Kenta Biotech AG
Arsanis Biosciences GmbH
Volcano Corporation
Abbott Laboratories
Angioscore Ltd.

Methicillin-Susceptible Staphylococcus Aureus Market

The global market for Methicillin-Susceptible Staphylococcus Aureus was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Methicillin-susceptible staphylococcus aureus infections are caused by gram-positive bacterium, which leads to skin allergies, pneumonia and endocarditis.
North American market for Methicillin-Susceptible Staphylococcus Aureus is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Methicillin-Susceptible Staphylococcus Aureus is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Methicillin-Susceptible Staphylococcus Aureus in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Methicillin-Susceptible Staphylococcus Aureus include Dainippon Sumitomo Pharma Co., Ltd, Immtech Pharmaceuticals, Inc., Lytix Biopharma AS, PharmaIN Corporation, Cubist Pharmaceuticals, Kenta Biotech AG, Arsanis Biosciences GmbH, Volcano Corporation, Abbott Laboratories, AngioScore Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Methicillin-Susceptible Staphylococcus Aureus, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Methicillin-Susceptible Staphylococcus Aureus.
The Methicillin-Susceptible Staphylococcus Aureus market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Methicillin-Susceptible Staphylococcus Aureus market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Methicillin-Susceptible Staphylococcus Aureus companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Methicillin-Susceptible Staphylococcus Aureus Market Report

Report Metric Details
Report Name Methicillin-Susceptible Staphylococcus Aureus Market
Segment by Type
  • Cephalosporins
  • Vancomycin
  • Linezolid
  • Others
Segment by Application
  • Hospitals
  • Clinics
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Dainippon Sumitomo Pharma Co., Ltd, Immtech Pharmaceuticals, Inc., Lytix Biopharma AS, PharmaIN Corporation, Cubist Pharmaceuticals, Kenta Biotech AG, Arsanis Biosciences GmbH, Volcano Corporation, Abbott Laboratories, AngioScore Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Methicillin-Susceptible Staphylococcus Aureus company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Methicillin-Susceptible Staphylococcus Aureus Market report?

Ans: The main players in the Methicillin-Susceptible Staphylococcus Aureus Market are Dainippon Sumitomo Pharma Co., Ltd, Immtech Pharmaceuticals, Inc., Lytix Biopharma AS, PharmaIN Corporation, Cubist Pharmaceuticals, Kenta Biotech AG, Arsanis Biosciences GmbH, Volcano Corporation, Abbott Laboratories, AngioScore Inc.

What are the Application segmentation covered in the Methicillin-Susceptible Staphylococcus Aureus Market report?

Ans: The Applications covered in the Methicillin-Susceptible Staphylococcus Aureus Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Methicillin-Susceptible Staphylococcus Aureus Market report?

Ans: The Types covered in the Methicillin-Susceptible Staphylococcus Aureus Market report are Cephalosporins, Vancomycin, Linezolid, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Methicillin-Susceptible Staphylococcus Aureus Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Cephalosporins
1.2.3 Vancomycin
1.2.4 Linezolid
1.2.5 Others
1.3 Market by Application
1.3.1 Global Methicillin-Susceptible Staphylococcus Aureus Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Methicillin-Susceptible Staphylococcus Aureus Market Perspective (2020-2031)
2.2 Global Methicillin-Susceptible Staphylococcus Aureus Growth Trends by Region
2.2.1 Global Methicillin-Susceptible Staphylococcus Aureus Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Methicillin-Susceptible Staphylococcus Aureus Historic Market Size by Region (2020-2025)
2.2.3 Methicillin-Susceptible Staphylococcus Aureus Forecasted Market Size by Region (2026-2031)
2.3 Methicillin-Susceptible Staphylococcus Aureus Market Dynamics
2.3.1 Methicillin-Susceptible Staphylococcus Aureus Industry Trends
2.3.2 Methicillin-Susceptible Staphylococcus Aureus Market Drivers
2.3.3 Methicillin-Susceptible Staphylococcus Aureus Market Challenges
2.3.4 Methicillin-Susceptible Staphylococcus Aureus Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Methicillin-Susceptible Staphylococcus Aureus Players by Revenue
3.1.1 Global Top Methicillin-Susceptible Staphylococcus Aureus Players by Revenue (2020-2025)
3.1.2 Global Methicillin-Susceptible Staphylococcus Aureus Revenue Market Share by Players (2020-2025)
3.2 Global Methicillin-Susceptible Staphylococcus Aureus Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Methicillin-Susceptible Staphylococcus Aureus Revenue
3.4 Global Methicillin-Susceptible Staphylococcus Aureus Market Concentration Ratio
3.4.1 Global Methicillin-Susceptible Staphylococcus Aureus Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Methicillin-Susceptible Staphylococcus Aureus Revenue in 2024
3.5 Global Key Players of Methicillin-Susceptible Staphylococcus Aureus Head office and Area Served
3.6 Global Key Players of Methicillin-Susceptible Staphylococcus Aureus, Product and Application
3.7 Global Key Players of Methicillin-Susceptible Staphylococcus Aureus, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Methicillin-Susceptible Staphylococcus Aureus Breakdown Data by Type
4.1 Global Methicillin-Susceptible Staphylococcus Aureus Historic Market Size by Type (2020-2025)
4.2 Global Methicillin-Susceptible Staphylococcus Aureus Forecasted Market Size by Type (2026-2031)
5 Methicillin-Susceptible Staphylococcus Aureus Breakdown Data by Application
5.1 Global Methicillin-Susceptible Staphylococcus Aureus Historic Market Size by Application (2020-2025)
5.2 Global Methicillin-Susceptible Staphylococcus Aureus Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Methicillin-Susceptible Staphylococcus Aureus Market Size (2020-2031)
6.2 North America Methicillin-Susceptible Staphylococcus Aureus Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2020-2025)
6.4 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size (2020-2031)
7.2 Europe Methicillin-Susceptible Staphylococcus Aureus Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2020-2025)
7.4 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size (2020-2031)
8.2 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Region (2020-2025)
8.4 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size (2020-2031)
9.2 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2020-2025)
9.4 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size (2020-2031)
10.2 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2020-2025)
10.4 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Dainippon Sumitomo Pharma Co., Ltd
11.1.1 Dainippon Sumitomo Pharma Co., Ltd Company Details
11.1.2 Dainippon Sumitomo Pharma Co., Ltd Business Overview
11.1.3 Dainippon Sumitomo Pharma Co., Ltd Methicillin-Susceptible Staphylococcus Aureus Introduction
11.1.4 Dainippon Sumitomo Pharma Co., Ltd Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2020-2025)
11.1.5 Dainippon Sumitomo Pharma Co., Ltd Recent Development
11.2 Immtech Pharmaceuticals, Inc.
11.2.1 Immtech Pharmaceuticals, Inc. Company Details
11.2.2 Immtech Pharmaceuticals, Inc. Business Overview
11.2.3 Immtech Pharmaceuticals, Inc. Methicillin-Susceptible Staphylococcus Aureus Introduction
11.2.4 Immtech Pharmaceuticals, Inc. Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2020-2025)
11.2.5 Immtech Pharmaceuticals, Inc. Recent Development
11.3 Lytix Biopharma AS
11.3.1 Lytix Biopharma AS Company Details
11.3.2 Lytix Biopharma AS Business Overview
11.3.3 Lytix Biopharma AS Methicillin-Susceptible Staphylococcus Aureus Introduction
11.3.4 Lytix Biopharma AS Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2020-2025)
11.3.5 Lytix Biopharma AS Recent Development
11.4 PharmaIN Corporation
11.4.1 PharmaIN Corporation Company Details
11.4.2 PharmaIN Corporation Business Overview
11.4.3 PharmaIN Corporation Methicillin-Susceptible Staphylococcus Aureus Introduction
11.4.4 PharmaIN Corporation Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2020-2025)
11.4.5 PharmaIN Corporation Recent Development
11.5 Cubist Pharmaceuticals
11.5.1 Cubist Pharmaceuticals Company Details
11.5.2 Cubist Pharmaceuticals Business Overview
11.5.3 Cubist Pharmaceuticals Methicillin-Susceptible Staphylococcus Aureus Introduction
11.5.4 Cubist Pharmaceuticals Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2020-2025)
11.5.5 Cubist Pharmaceuticals Recent Development
11.6 Kenta Biotech AG
11.6.1 Kenta Biotech AG Company Details
11.6.2 Kenta Biotech AG Business Overview
11.6.3 Kenta Biotech AG Methicillin-Susceptible Staphylococcus Aureus Introduction
11.6.4 Kenta Biotech AG Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2020-2025)
11.6.5 Kenta Biotech AG Recent Development
11.7 Arsanis Biosciences GmbH
11.7.1 Arsanis Biosciences GmbH Company Details
11.7.2 Arsanis Biosciences GmbH Business Overview
11.7.3 Arsanis Biosciences GmbH Methicillin-Susceptible Staphylococcus Aureus Introduction
11.7.4 Arsanis Biosciences GmbH Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2020-2025)
11.7.5 Arsanis Biosciences GmbH Recent Development
11.8 Volcano Corporation
11.8.1 Volcano Corporation Company Details
11.8.2 Volcano Corporation Business Overview
11.8.3 Volcano Corporation Methicillin-Susceptible Staphylococcus Aureus Introduction
11.8.4 Volcano Corporation Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2020-2025)
11.8.5 Volcano Corporation Recent Development
11.9 Abbott Laboratories
11.9.1 Abbott Laboratories Company Details
11.9.2 Abbott Laboratories Business Overview
11.9.3 Abbott Laboratories Methicillin-Susceptible Staphylococcus Aureus Introduction
11.9.4 Abbott Laboratories Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2020-2025)
11.9.5 Abbott Laboratories Recent Development
11.10 AngioScore Inc.
11.10.1 AngioScore Inc. Company Details
11.10.2 AngioScore Inc. Business Overview
11.10.3 AngioScore Inc. Methicillin-Susceptible Staphylococcus Aureus Introduction
11.10.4 AngioScore Inc. Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2020-2025)
11.10.5 AngioScore Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Dainippon Sumitomo Pharma Co., Ltd
Immtech Pharmaceuticals, Inc.
Lytix Biopharma AS
PharmaIN Corporation
Cubist Pharmaceuticals
Kenta Biotech AG
Arsanis Biosciences GmbH
Volcano Corporation
Abbott Laboratories
Angioscore Ltd.
List of Tables
 Table 1. Global Methicillin-Susceptible Staphylococcus Aureus Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Cephalosporins
 Table 3. Key Players of Vancomycin
 Table 4. Key Players of Linezolid
 Table 5. Key Players of Others
 Table 6. Global Methicillin-Susceptible Staphylococcus Aureus Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Methicillin-Susceptible Staphylococcus Aureus Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Methicillin-Susceptible Staphylococcus Aureus Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Methicillin-Susceptible Staphylococcus Aureus Market Share by Region (2020-2025)
 Table 10. Global Methicillin-Susceptible Staphylococcus Aureus Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Methicillin-Susceptible Staphylococcus Aureus Market Share by Region (2026-2031)
 Table 12. Methicillin-Susceptible Staphylococcus Aureus Market Trends
 Table 13. Methicillin-Susceptible Staphylococcus Aureus Market Drivers
 Table 14. Methicillin-Susceptible Staphylococcus Aureus Market Challenges
 Table 15. Methicillin-Susceptible Staphylococcus Aureus Market Restraints
 Table 16. Global Methicillin-Susceptible Staphylococcus Aureus Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Methicillin-Susceptible Staphylococcus Aureus Market Share by Players (2020-2025)
 Table 18. Global Top Methicillin-Susceptible Staphylococcus Aureus Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Methicillin-Susceptible Staphylococcus Aureus as of 2024)
 Table 19. Ranking of Global Top Methicillin-Susceptible Staphylococcus Aureus Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Methicillin-Susceptible Staphylococcus Aureus Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Methicillin-Susceptible Staphylococcus Aureus, Headquarters and Area Served
 Table 22. Global Key Players of Methicillin-Susceptible Staphylococcus Aureus, Product and Application
 Table 23. Global Key Players of Methicillin-Susceptible Staphylococcus Aureus, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Methicillin-Susceptible Staphylococcus Aureus Revenue Market Share by Type (2020-2025)
 Table 27. Global Methicillin-Susceptible Staphylococcus Aureus Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Methicillin-Susceptible Staphylococcus Aureus Revenue Market Share by Type (2026-2031)
 Table 29. Global Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Methicillin-Susceptible Staphylococcus Aureus Revenue Market Share by Application (2020-2025)
 Table 31. Global Methicillin-Susceptible Staphylococcus Aureus Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Methicillin-Susceptible Staphylococcus Aureus Revenue Market Share by Application (2026-2031)
 Table 33. North America Methicillin-Susceptible Staphylococcus Aureus Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Methicillin-Susceptible Staphylococcus Aureus Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Dainippon Sumitomo Pharma Co., Ltd Company Details
 Table 49. Dainippon Sumitomo Pharma Co., Ltd Business Overview
 Table 50. Dainippon Sumitomo Pharma Co., Ltd Methicillin-Susceptible Staphylococcus Aureus Product
 Table 51. Dainippon Sumitomo Pharma Co., Ltd Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2020-2025) & (US$ Million)
 Table 52. Dainippon Sumitomo Pharma Co., Ltd Recent Development
 Table 53. Immtech Pharmaceuticals, Inc. Company Details
 Table 54. Immtech Pharmaceuticals, Inc. Business Overview
 Table 55. Immtech Pharmaceuticals, Inc. Methicillin-Susceptible Staphylococcus Aureus Product
 Table 56. Immtech Pharmaceuticals, Inc. Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2020-2025) & (US$ Million)
 Table 57. Immtech Pharmaceuticals, Inc. Recent Development
 Table 58. Lytix Biopharma AS Company Details
 Table 59. Lytix Biopharma AS Business Overview
 Table 60. Lytix Biopharma AS Methicillin-Susceptible Staphylococcus Aureus Product
 Table 61. Lytix Biopharma AS Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2020-2025) & (US$ Million)
 Table 62. Lytix Biopharma AS Recent Development
 Table 63. PharmaIN Corporation Company Details
 Table 64. PharmaIN Corporation Business Overview
 Table 65. PharmaIN Corporation Methicillin-Susceptible Staphylococcus Aureus Product
 Table 66. PharmaIN Corporation Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2020-2025) & (US$ Million)
 Table 67. PharmaIN Corporation Recent Development
 Table 68. Cubist Pharmaceuticals Company Details
 Table 69. Cubist Pharmaceuticals Business Overview
 Table 70. Cubist Pharmaceuticals Methicillin-Susceptible Staphylococcus Aureus Product
 Table 71. Cubist Pharmaceuticals Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2020-2025) & (US$ Million)
 Table 72. Cubist Pharmaceuticals Recent Development
 Table 73. Kenta Biotech AG Company Details
 Table 74. Kenta Biotech AG Business Overview
 Table 75. Kenta Biotech AG Methicillin-Susceptible Staphylococcus Aureus Product
 Table 76. Kenta Biotech AG Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2020-2025) & (US$ Million)
 Table 77. Kenta Biotech AG Recent Development
 Table 78. Arsanis Biosciences GmbH Company Details
 Table 79. Arsanis Biosciences GmbH Business Overview
 Table 80. Arsanis Biosciences GmbH Methicillin-Susceptible Staphylococcus Aureus Product
 Table 81. Arsanis Biosciences GmbH Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2020-2025) & (US$ Million)
 Table 82. Arsanis Biosciences GmbH Recent Development
 Table 83. Volcano Corporation Company Details
 Table 84. Volcano Corporation Business Overview
 Table 85. Volcano Corporation Methicillin-Susceptible Staphylococcus Aureus Product
 Table 86. Volcano Corporation Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2020-2025) & (US$ Million)
 Table 87. Volcano Corporation Recent Development
 Table 88. Abbott Laboratories Company Details
 Table 89. Abbott Laboratories Business Overview
 Table 90. Abbott Laboratories Methicillin-Susceptible Staphylococcus Aureus Product
 Table 91. Abbott Laboratories Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2020-2025) & (US$ Million)
 Table 92. Abbott Laboratories Recent Development
 Table 93. AngioScore Inc. Company Details
 Table 94. AngioScore Inc. Business Overview
 Table 95. AngioScore Inc. Methicillin-Susceptible Staphylococcus Aureus Product
 Table 96. AngioScore Inc. Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2020-2025) & (US$ Million)
 Table 97. AngioScore Inc. Recent Development
 Table 98. Research Programs/Design for This Report
 Table 99. Key Data Information from Secondary Sources
 Table 100. Key Data Information from Primary Sources
 Table 101. Authors List of This Report


List of Figures
 Figure 1. Methicillin-Susceptible Staphylococcus Aureus Picture
 Figure 2. Global Methicillin-Susceptible Staphylococcus Aureus Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Methicillin-Susceptible Staphylococcus Aureus Market Share by Type: 2024 VS 2031
 Figure 4. Cephalosporins Features
 Figure 5. Vancomycin Features
 Figure 6. Linezolid Features
 Figure 7. Others Features
 Figure 8. Global Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Methicillin-Susceptible Staphylococcus Aureus Market Share by Application: 2024 VS 2031
 Figure 10. Hospitals Case Studies
 Figure 11. Clinics Case Studies
 Figure 12. Others Case Studies
 Figure 13. Methicillin-Susceptible Staphylococcus Aureus Report Years Considered
 Figure 14. Global Methicillin-Susceptible Staphylococcus Aureus Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Methicillin-Susceptible Staphylococcus Aureus Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Methicillin-Susceptible Staphylococcus Aureus Market Share by Region: 2024 VS 2031
 Figure 17. Global Methicillin-Susceptible Staphylococcus Aureus Market Share by Players in 2024
 Figure 18. Global Top Methicillin-Susceptible Staphylococcus Aureus Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Methicillin-Susceptible Staphylococcus Aureus as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Methicillin-Susceptible Staphylococcus Aureus Revenue in 2024
 Figure 20. North America Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Methicillin-Susceptible Staphylococcus Aureus Market Share by Country (2020-2031)
 Figure 22. United States Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Methicillin-Susceptible Staphylococcus Aureus Market Share by Country (2020-2031)
 Figure 26. Germany Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Share by Region (2020-2031)
 Figure 34. China Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Methicillin-Susceptible Staphylococcus Aureus Market Share by Country (2020-2031)
 Figure 42. Mexico Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Share by Country (2020-2031)
 Figure 46. Turkey Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Dainippon Sumitomo Pharma Co., Ltd Revenue Growth Rate in Methicillin-Susceptible Staphylococcus Aureus Business (2020-2025)
 Figure 50. Immtech Pharmaceuticals, Inc. Revenue Growth Rate in Methicillin-Susceptible Staphylococcus Aureus Business (2020-2025)
 Figure 51. Lytix Biopharma AS Revenue Growth Rate in Methicillin-Susceptible Staphylococcus Aureus Business (2020-2025)
 Figure 52. PharmaIN Corporation Revenue Growth Rate in Methicillin-Susceptible Staphylococcus Aureus Business (2020-2025)
 Figure 53. Cubist Pharmaceuticals Revenue Growth Rate in Methicillin-Susceptible Staphylococcus Aureus Business (2020-2025)
 Figure 54. Kenta Biotech AG Revenue Growth Rate in Methicillin-Susceptible Staphylococcus Aureus Business (2020-2025)
 Figure 55. Arsanis Biosciences GmbH Revenue Growth Rate in Methicillin-Susceptible Staphylococcus Aureus Business (2020-2025)
 Figure 56. Volcano Corporation Revenue Growth Rate in Methicillin-Susceptible Staphylococcus Aureus Business (2020-2025)
 Figure 57. Abbott Laboratories Revenue Growth Rate in Methicillin-Susceptible Staphylococcus Aureus Business (2020-2025)
 Figure 58. AngioScore Inc. Revenue Growth Rate in Methicillin-Susceptible Staphylococcus Aureus Business (2020-2025)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Methicillin Resistant Staphylococcus Aureus Testing Market Research Report 2024
Global Methicillin Resistant Staphylococcus Aureus MRSA Treatment Market Research Report 2024
Methicillin Resistant Staphylococcus Aureus Infection Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
MRSA Antibiotic Preparations Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Staphylococcal Infection Drugs Market Insights Forecast to 2030
Global Methicillin resistant Staphylococcus Aureus MRSA Testing Systems Market Insights Forecast to 2030
Global Vancomycin Market Research Report 2024
Methicillin Resistant Staphylococcus Aureus MRSA Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
MRSA Antibiotics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global MRSA Drugs Market Research Report 2025
Global Staphylococcal Infection Treatment Market Insights Forecast to 2030
VRE and MRSA Antibiotic Market
Global MRSA Testing Devices Market Research Report 2025
Global Clostridium Difficile Infection Treatment Market Research Report 2024
Global Enterobacteriaceae Infection Drug Market Research Report 2024
Global Gram positive Bacterial Infection Drugs Market Research Report 2024
Global Legionnaire Disease Testing Market Research Report 2024
Global Linezolid Drug Market Research Report 2024
Global Mupirocin for Bedsores Market Research Report 2025
Teicoplanin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Hepatitis B Virus Core Antibody Diagnostic Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-21N6899
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Pediatric Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13M6952
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Poliomyelitis Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29X7355
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Varicella Virus (Chickenpox) Vaccine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28B293
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions